These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12754355)

  • 1. Predictors of cognitive impairment in advanced Parkinson's disease.
    Vingerhoets G; Verleden S; Santens P; Miatton M; De Reuck J
    J Neurol Neurosurg Psychiatry; 2003 Jun; 74(6):793-6. PubMed ID: 12754355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in Parkinson's disease: Association between patient-reported and clinically measured outcomes.
    Mills KA; Mari Z; Pontone GM; Pantelyat A; Zhang A; Yoritomo N; Powers E; Brandt J; Dawson TM; Rosenthal LS
    Parkinsonism Relat Disord; 2016 Dec; 33():107-114. PubMed ID: 27733275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological prediction of dementia in Parkinson's disease.
    Mahieux F; Fénelon G; Flahault A; Manifacier MJ; Michelet D; Boller F
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):178-83. PubMed ID: 9489527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early impairment of cognitive functions in Parkinson's disease.
    Stella F; Gobbi LT; Gobbi S; Oliani MM; Tanaka K; Pieruccini-Faria F
    Arq Neuropsiquiatr; 2007 Jun; 65(2B):406-10. PubMed ID: 17665005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings.
    Chahine LM; Weintraub D; Hawkins KA; Siderowf A; Eberly S; Oakes D; Seibyl J; Stern MB; Marek K; Jennings D;
    Mov Disord; 2016 Jan; 31(1):86-94. PubMed ID: 26293177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson's disease.
    Domellöf ME; Elgh E; Forsgren L
    Mov Disord; 2011 Oct; 26(12):2183-9. PubMed ID: 21661051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using executive heterogeneity to explore the nature of working memory deficits in Parkinson's disease.
    Lewis SJ; Cools R; Robbins TW; Dove A; Barker RA; Owen AM
    Neuropsychologia; 2003; 41(6):645-54. PubMed ID: 12591022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive function assessment in idiopathic Parkinson's disease.
    Piovezan MR; Teive HA; Piovesan EJ; Mader MJ; Werneck LC
    Arq Neuropsiquiatr; 2007 Dec; 65(4A):942-6. PubMed ID: 18094850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
    Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
    Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which factors predict cognitive decline in Parkinson's disease?
    Caparros-Lefebvre D; Pécheux N; Petit V; Duhamel A; Petit H
    J Neurol Neurosurg Psychiatry; 1995 Jan; 58(1):51-5. PubMed ID: 7823067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domain-specific accuracy of the Montreal Cognitive Assessment subsections in Parkinson's disease.
    Hendershott TR; Zhu D; Llanes S; Poston KL
    Parkinsonism Relat Disord; 2017 May; 38():31-34. PubMed ID: 28215728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study.
    Hanagasi HA; Gurvit H; Unsalan P; Horozoglu H; Tuncer N; Feyzioglu A; Gunal DI; Yener GG; Cakmur R; Sahin HA; Emre M
    Mov Disord; 2011 Aug; 26(10):1851-8. PubMed ID: 21500280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.
    Pagonabarraga J; Kulisevsky J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A
    Mov Disord; 2008 May; 23(7):998-1005. PubMed ID: 18381647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease.
    Mengel D; Dams J; Ziemek J; Becker J; Balzer-Geldsetzer M; Hilker R; Baudrexel S; Kalbe E; Schmidt N; Witt K; Liepelt-Scarfone I; Gräber S; Petrelli A; Neuser P; Schulte C; Linse K; Storch A; Wittchen HU; Riedel O; Mollenhauer B; Ebentheuer J; Trenkwalder C; Klockgether T; Spottke A; Wüllner U; Schulz JB; Reetz K; Heber IA; Ramirez A; Dodel R
    Parkinsonism Relat Disord; 2016 Aug; 29():112-6. PubMed ID: 27321987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of cognitive dysfunction in Parkinson's disease: a cohort study.
    Verleden S; Vingerhoets G; Santens P
    Eur Neurol; 2007; 58(1):34-40. PubMed ID: 17483583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Parkinson's Disease-Cognitive Rating Scale (PD-CRS): normative values from 268 healthy Italian individuals.
    Santangelo G; Lagravinese G; Battini V; Chiorri C; Siciliano M; Abbruzzese G; Vitale C; Barone P
    Neurol Sci; 2017 May; 38(5):845-853. PubMed ID: 28224328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2.
    Estanga A; Rodriguez-Oroz MC; Ruiz-Martinez J; Barandiaran M; Gorostidi A; Bergareche A; Mondragon E; Lopez de Munain A; Marti-Masso JF
    Parkinsonism Relat Disord; 2014 Oct; 20(10):1097-100. PubMed ID: 25127457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.
    Gasca-Salas C; Estanga A; Clavero P; Aguilar-Palacio I; González-Redondo R; Obeso JA; Rodríguez-Oroz MC
    J Parkinsons Dis; 2014; 4(4):677-86. PubMed ID: 25208730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.